TEVA-COTRIDIN EXPECTORANT
TEVA-COTRIDIN EXPECTORANT
Approved
DIN Number
02053403
Drug Class
Human
Market Date
Dec 31, 1994
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02053403
AIG Number0403192001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS
Product Specifications
Dosage FormSyrup
Route of AdministrationOral
AHFS Classification48:08.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
CODEINE PHOSPHATEActive
Strength: 10 MG / 5 ML
Monograph: CODEINE PHOSPHATE
GUAIFENESINActive
Strength: 100 MG / 5 ML
Monograph: GUAIFENESIN
PSEUDOEPHEDRINE HYDROCHLORIDEActive
Strength: 30 MG / 5 ML
Monograph: PSEUDOEPHEDRINE HYDROCHLORIDE
TRIPROLIDINE HYDROCHLORIDEActive
Strength: 2 MG / 5 ML
Monograph: TRIPROLIDINE HYDROCHLORIDE